PRELUDE CAPITAL MANAGEMENT, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 162 filers reported holding NEVRO CORP in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2023$320,928
+58.9%
12,625
+191.4%
0.02%
+200.0%
Q3 2022$202,000
-77.4%
4,332
-19.5%
0.01%
-74.1%
Q2 2021$892,000
+925.3%
5,380
+432.7%
0.03%
+575.0%
Q3 2019$87,000
+4.8%
1,010
-21.1%
0.00%0.0%
Q2 2019$83,000
+93.0%
1,280
+84.7%
0.00%
+100.0%
Q1 2019$43,000
-96.0%
693
-96.3%
0.00%
-96.8%
Q3 2018$1,078,000
+102.6%
18,912
+184.0%
0.06%
+85.3%
Q2 2018$532,000
-43.7%
6,659
-38.9%
0.03%
-50.7%
Q1 2018$945,000
-18.8%
10,900
-35.3%
0.07%
-25.8%
Q4 2017$1,164,000
-12.7%
16,858
+14.9%
0.09%
-22.5%
Q3 2017$1,333,000
-46.4%
14,667
-56.1%
0.12%
-49.2%
Q2 2017$2,489,000
+103.3%
33,443
+156.0%
0.24%
+101.7%
Q1 2017$1,224,000
+120.1%
13,063
+70.8%
0.12%
+74.6%
Q4 2016$556,000
-69.4%
7,649
-56.1%
0.07%
-64.9%
Q3 2016$1,819,000
+390.3%
17,422
+246.5%
0.19%
+267.3%
Q2 2016$371,000
+145.7%
5,028
+87.3%
0.05%
+147.6%
Q1 2016$151,000
+235.6%
2,685
+303.8%
0.02%
+200.0%
Q4 2015$45,000
-62.2%
665
-74.1%
0.01%
-58.8%
Q3 2015$119,0002,5650.02%
Other shareholders
NEVRO CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders